Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (451-460 of 491) with videos related to

Pageof 50
Sort By:
Journal of Hepatology|September 24, 2022
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosisJiří Reiniš, Oleksandr Petrenko, Benedikt Simbrunner, et al.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
Journal of Hepatology|November 5, 2025
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Paul Thöne, Aitor Odriozola, et al.
Hepatology (Baltimore, Md.)|July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Hepatology (Baltimore, Md.)|January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology|September 5, 2022
Non-invasive tests for clinically significant portal hypertension after HCV cureGeorg Semmler, Sabela Lens, Elias L Meyer, et al.
Journal of Hepatology|March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
JHEP Reports : Innovation in Hepatology|November 25, 2024
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter studyValeria Perez-Campuzano, Pierre-Emmanuel Rautou, Thomas Marjot, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2024
A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE projectLorenz Balcar, Michael Schwarz, Livia Dorn, et al.
Wiener Klinische Wochenschrift|September 29, 2023
ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in AustriaCaroline Schwarz, David Bauer, Livia Dorn, et al.
Pageof 50

Showing results (451-460 of 491) with videos related to

Sort By:
Pageof 50
Journal of Hepatology|September 24, 2022
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosisJiří Reiniš, Oleksandr Petrenko, Benedikt Simbrunner, et al.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
Journal of Hepatology|November 5, 2025
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Paul Thöne, Aitor Odriozola, et al.
Hepatology (Baltimore, Md.)|July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Hepatology (Baltimore, Md.)|January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
Journal of Hepatology|September 5, 2022
Non-invasive tests for clinically significant portal hypertension after HCV cureGeorg Semmler, Sabela Lens, Elias L Meyer, et al.
Journal of Hepatology|March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.
JHEP Reports : Innovation in Hepatology|November 25, 2024
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter studyValeria Perez-Campuzano, Pierre-Emmanuel Rautou, Thomas Marjot, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2024
A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE projectLorenz Balcar, Michael Schwarz, Livia Dorn, et al.
Wiener Klinische Wochenschrift|September 29, 2023
ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in AustriaCaroline Schwarz, David Bauer, Livia Dorn, et al.
Pageof 50